HomeInsightsPE

Indoco Remedies Ltd PE Ratio

Indoco Remedies Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

1.6 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Indoco Remedies Ltd

NSE: INDOCO

PE

128.3

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Indoco Remedies Ltd is 128.3 as of 12 Dec 13:07 PM .
  • The P/E Ratio of Indoco Remedies Ltd changed from 79.9 on March 2020 to 30.8 on March 2024 . This represents a CAGR of -17.36% over 5 years.
  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 332.1 as of 12 Dec 13:00 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Indoco Remedies Ltd

No data available

Company Fundamentals for Indoco Remedies Ltd

No data available

Image

Indoco Remedies Ltd

NSE: INDOCO

Share Price

₹ 332.1

-9.20 (-2.70%)

stock direction

Last updated on: Dec 12, 2024

Market Price of Indoco Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Indoco Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024341.3
10 Dec 2024339.05
09 Dec 2024318.5
06 Dec 2024323.65
05 Dec 2024320.5
04 Dec 2024322.55
03 Dec 2024321.1
02 Dec 2024322
29 Nov 2024324.85
28 Nov 2024315.2

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Indoco Remedies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Indoco Remedies Ltd1283,146
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Indoco Remedies Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Revenue of Indoco Remedies Ltd

No data available

* All values are in crore

Historical EBITDA of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Dividend Payout of Indoco Remedies Ltd

No data available

* All values are in %

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

Indoco Remedies Ltd News Hub

News

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New...

Read more

2024-08-21 00:00:00

News

Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets

The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been gran...

Read more

2024-08-21 00:00:00

News

Indoco Remedies fixes record date for final dividend

Indoco Remedies has fixed 19 September 2024 as record date for determining entitlement of ...

Read more

2024-08-30 00:00:00

News

Indoco Remedies AGM scheduled

Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

2024-08-31 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Indoco Remedies Ltd

What is the current PE Ratio of Indoco Remedies Ltd?

The Current PE Ratio of Indoco Remedies Ltd is 128.31 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Indoco Remedies Ltd last year?

The PE Ratio of Indoco Remedies Ltd was 21.08 last year, now the PE ratio is 128.31, showing a year-on-year growth of 508.7%.

What does the PE Ratio of Indoco Remedies Ltd indicate about its stock?

The PE Ratio of Indoco Remedies Ltd is 128.31. This ratio indicates that investors are willing to pay 128.31 times the earnings per share for each share of Indoco Remedies Ltd.

What is the PE Ratio Growth of Indoco Remedies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Indoco Remedies Ltd grew by 508.7% whereas, the EPS ratio grew by -645.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions